Abstract
The respective effects of three antidepressant drugs (moclobemide, 450 mg/j; viloxazine, 300 mg/j; maprotiline, 150 mg/j) on vigilance, attention, and memory were compared. Young depressed outpatients (n=46) entered a double-blind, randomised, monocentre clinical trial lasting for 6 weeks. Drug actions were assessed through the regular determination of critical flicker fusion point (CFF), reaction times (SRT), and a battery to measure memory components. None of the three drugs caused deterioration in cognitive functions. On the other hand, moclobemide improved both vigilance and attention (CFF, SRT) and some crucial components of memory (general memory scores, delayed word recall, recognition of familiar faces). This effect was rapid, stable, and superior to those of viloxazine and maprotiline. It may be explained by moclobemide's selective and reversible inhibition of monoamine oxidase A, as well as by the lack of any anticholinergic action.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allain H, Bentue-Ferrer D, Decombe R (1990) The pharmacology of antidepressants and senile dementia: Fondation Nationale de Gérontologie, Maloine, Paris, pp 111–121
Caillard V (1990) Are all depressions serotoninergic? Visage de la Dépression, pp 18–20
Calev A, Korin Y, Shapira B, Kugelmass S, Lerer B (1986) Verbal and non verbal recall by depressed and euthymic affective patients. Psychol Med 16:789–794
Bleuler E (1972) Lehrbuch der Psychiatrie, 12th edn. Springer, Berlin Heidelberg New York
Curran HV, Sakulsriprong M, Lader M (1988) Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 4:520–527
Kraepelin E (1927) „Psychiatrie“ 9th Ed. Barth, Leipzig
Legg JF, Stiff MP (1976) Drug related test patterns of depressant patients. Psychopharmacology 50:205–210
Lieury A, Trebon P, Boujon C, Bernoussi M, Allain H (1991) Ageing of memory components: factorial analysis of 17 memory scores. Ann Psychol (Paris) 91:169–186
Miller WR (1975) Psychological deficit in depression. Psychol Bull 82:238–260
Moskowitz H, Burns M (1986) Cognitive performance in geriatric subjects after acute treatment with antidepressants. Neuropsychobiology 15 (suppl 1):38–43
Saletu BJ, Grunberger J, Rajna P, Karobath M (1980) Clovoxamine and fluvoxamine-2 biogenic amine reuptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetics studies in man. J Neurol Transm 49:63–86
Siegfried K (1985) Cognitive symptoms in late-life depression and their treatment. J Affect Dis Suppl 1:533–540
Siegfried KR, Jansen W, Pahnke K (1984) Cognitive dysfunction in depression: difference between depressed and non depressed elderly patients and differential cognitive effects of nomifensine. Drug Dev Res 4:533–543
Taeuber KJ, Zaff RJ, Rupp W, Bandian M (1979) Pharmacodynamic comparison of the acute effects of nomifensin amphetamine and placebo in healthy volunteers. J Clin Pharmacol Biopharm 17:32–37
Tariot PN, Sunderland T, Weingartner H, Murphy D, Wezkowitz J, Thompson K, Cohen RM (1987) Cognitive effect of L-Deprenyl in Alzheimer's disease. Psychopharmacology 91:489–495
Thompson C, Isaacs G (1991) Is viloxazine an antidepressant? a placebo-controlled double-blind study in major depressive disorder presenting in a general hospital. Hum Psychopharmacol 6:31–38
Thompson P, Trimble MR (1982) Non-MAOI antidepressant drugs and cognitive functions: a review. Psychol Med 12:539–548
Weckowicz T, Nutter RW, Cruise D, Young K (1972) Speed in test performance in relation to depressive illness and age. Can Psychiat Assoc J 17:241–250
Wesnes K, Simpson P, Christma S, Anand R, McClelland G (1989) The effects of moclobemide on cognition. J Neural Transm (suppl) 28:91–102
Wolfe J, Granholm E, Butters N, Saunders E, Janowsky D (1987) Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients. J Affect Dis 13:83–92
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allain, H., Lieury, A., Brunet-Bourgin, F. et al. Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology 106 (Suppl 1), S56–S61 (1992). https://doi.org/10.1007/BF02246237
Issue Date:
DOI: https://doi.org/10.1007/BF02246237